Pharma & Biotech

Evolus Inc. shares experienced a notable decline of 4.26% during Friday's trading session, closing at $7.19. This downward movement coincided...

Advanced Micro Devices (AMD) finds itself navigating contrasting narratives as it pursues leadership in artificial intelligence while facing intensified examination...

Investors are reassessing Viking Therapeutics' clinical trial data as concerns emerge about patient discontinuation rates in the study of oral...

Despite delivering a series of positive developments, including new product launches and robust quarterly results, OrthoPediatrics shares are experiencing significant...

Intercept Pharmaceuticals faces a severe market downturn after the biopharma firm initiated a voluntary withdrawal of its key medication, Ocaliva,...

Shares of Australian biotechnology firm Mesoblast Limited experienced significant downward momentum in recent trading sessions. The company's stock listed on...

The biosimulation company Simulations Plus finds itself navigating the most turbulent period in its recent history. A combination of legal...

Biotechnology firm United Therapeutics enters a pivotal period as market participants await a major medical conference presentation. The company's stock...

Friday proved to be a turbulent day for pharmaceutical giant Eli Lilly, with three significant developments creating a complex picture...

Medical device specialist Utah Medical Products is confronting significant headwinds, with its latest quarterly results revealing a pronounced contraction in...